Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Serstech (Q3 Review) - Market turning with share at 52-week low

Serstech

Redeye updates its estimates and valuation following Serstech’s Q3 2025 report. Sales and profitability were better than expected, despite no larger orders being announced beforehand. The company also finalised its planned recruitments, meaning that sales and R&D capabilities are now significantly stronger than a year ago. We also learn that two new devices have been developed and are scheduled for release in Q1 2026. We make only minor changes to our estimates and valuation and look forward to following the effects of recent initiatives in 2026e and beyond.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Serstech (Q3 Review) - Market turning with share at 52-week low

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.